Literature DB >> 22726072

A case of unclassified multicystic biliary tumor with biliary adenofibroma features.

Keita Kai1, Tomomi Yakabe, Naohiko Kohya, Atsushi Miyoshi, Shinji Iwane, Toshihiko Mizuta, Kohji Miyazaki, Osamu Tokunaga.   

Abstract

A 40-year-old Japanese man was admitted to our hospital for evaluation of upper abdominal pain. Abdominal computed tomography (CT) revealed a well-circumscribed multicystic mass measuring approximately 7 × 6 cm. The mass contained a solid lesion measuring 3 × 2 cm. Biopsy of a swollen cervical lymph node led to a diagnosis of diffuse large B-cell lymphoma. After initial chemotherapy for lymphoma, the multicystic mass was surgically resected. The tumor was composed of a multicystic lesion and a solid lesion. Histopathologic examination of the multicystic lesion revealed that the locules were lined by biliary epithelium, demonstrating various degrees of cytological atypia. The stroma was fibrous, and the tumor showed marked apocrine snouts. Part of the tumor showed papillary growth with strong cytological atypia. The solid lesion showed tubulocystic proliferation of tumor cells, with prominent apocrine snouts, embedded in dense and partially hyalinized fibrous stroma. The morphology of the solid part was quite similar to that of reported biliary adenofibroma. Despite lengthy discussion, an appropriate pathological diagnosis could not be found among the current classifications of biliary tumor. The tumor was finally diagnosed as unclassified multicystic biliary tumor with adenofibroma features.
© 2012 The Authors. Pathology International © 2012 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22726072     DOI: 10.1111/j.1440-1827.2012.02830.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  9 in total

1.  Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor.

Authors:  Scott M Thompson; Benjamin Zendejas-Mummert; Mindy L Hartgers; Sudhakar K Venkatesh; Thomas C Smyrk; Amit Mahipal; Rory L Smoot
Journal:  J Gastrointest Oncol       Date:  2016-12

2.  Imaging presentation of biliary adenofibroma: A case report.

Authors:  Shao-Peng Li; Peng Wang; Ke-Xue Deng
Journal:  World J Clin Cases       Date:  2022-02-06       Impact factor: 1.337

3.  Biliary Adenofibroma: A Rare Liver Tumor with Transition to Invasive Carcinoma.

Authors:  Ayham Alshbib; Krzysztof Grzyb; Trygve Syversveen; Henrik Mikael Reims; Kristoffer Lassen; Sheraz Yaqub
Journal:  Case Rep Surg       Date:  2022-02-07

4.  Imaging features of biliary adenofibroma of the liver with malignant transformation: a case report with literature review.

Authors:  Wenjun Hu; Ying Zhao; Yunsong Liu; Zhengyu Hua; Ailian Liu
Journal:  BMC Med Imaging       Date:  2022-03-17       Impact factor: 1.930

5.  Atypical Biliary Adenofibroma of the Liver: Related Treatment and Performance.

Authors:  Shao-Ru Liu; Qi Zhu; Ming-Bin Feng; Qing Yan; Tai-Feng Zhu; Lei-Bo Xu
Journal:  Case Rep Gastroenterol       Date:  2022-08-31

6.  Malignant transformation of biliary adenofibroma combined with benign lymphadenopathy mimicking advanced liver carcinoma: A case report.

Authors:  Shao-Cheng Wang; Yan-Yan Chen; Fei Cheng; Hai-Yong Wang; Fu-Sheng Wu; Li-Song Teng
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

7.  Biliary Adenofibroma with Invasive Carcinoma: Case Report and Review of the Literature.

Authors:  Anjali Godambe; Elizabeth M Brunt; Keith H Fulling; Taher Reza Kermanshahi
Journal:  Case Rep Pathol       Date:  2016-01-13

8.  Double Trouble: A Rare Case of Concurrent Biliary Adenofibroma and Hepatobiliary Mucinous Cystic Neoplasm.

Authors:  Marcus Esteban; Jaimin Amin; Martin Hertl; Shriram Jakate; Ajaypal Singh
Journal:  ACG Case Rep J       Date:  2018-10-17

9.  Incidental biliary adenofibroma with dysplastic features.

Authors:  M A Jacobs; C Lanciault; S Weinstein
Journal:  BJR Case Rep       Date:  2015-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.